2021
DOI: 10.3389/fbioe.2021.763031
|View full text |Cite
|
Sign up to set email alerts
|

Microbial-Derived Polyhydroxyalkanoate-Based Scaffolds for Bone Tissue Engineering: Biosynthesis, Properties, and Perspectives

Abstract: Polyhydroxyalkanoates (PHAs) are a class of structurally diverse natural biopolyesters, synthesized by various microbes under unbalanced culture conditions. PHAs as biomedical materials have been fabricated in various forms to apply to tissue engineering for the past years due to their excellent biodegradability, inherent biocompatibility, modifiable mechanical properties, and thermo-processability. However, there remain some bottlenecks in terms of PHA production on a large scale, the purification process, me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 159 publications
(103 reference statements)
0
7
0
Order By: Relevance
“…[156] However, PHAs' relatively hydrophobic nature and weak mechanical characteristics have largely limited their application. [157]…”
Section: Piezoelectric Materialsmentioning
confidence: 99%
“…[156] However, PHAs' relatively hydrophobic nature and weak mechanical characteristics have largely limited their application. [157]…”
Section: Piezoelectric Materialsmentioning
confidence: 99%
“…PHAs are purified using many techniques, such as precipitation, filtration, centrifugation, or chromatography. Their performance and properties depend on the purification [35,36].…”
Section: Polyhydroxyalkanoates (Phas)mentioning
confidence: 99%
“…The efficiency of the production process with a low polymer concentration and high substrate cost must also be taken into account, as providing a large-scale production process is economically impracticable. Recent research in tissue engineering using PHAs has been mainly aimed at wound management [ 106 , 107 ], nerve regeneration [ 108 ], cardiac- and coronary-related tissue engineering, and bone reconstruction [ 49 , 105 , 109 , 110 ]. Due to relatively low market availability, only a few of more than 90 known PHAs are available.…”
Section: Tissue Engineeringmentioning
confidence: 99%